Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

The man accused of fatally shooting a man while in a moving car, resulting in a crash, appeared in court Wednesday on a murder charge. 1 killed, 1 hospitalized after head-on crash in Reading It ...

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...

Generate Capital PBC, an investment firm that has raised more than $14 billion since 2014 to bankroll largely US-based sustainable projects, has cut staff as the withdrawal of US policy support upends ...

STAY WITH WMUR BOTH ON AIR AND ONLINE FOR THE LATEST ON THIS DEVELOPING STORY... WE'LL ALSO HAVE ALL OF THE OVERNIGHT DEVELOPMENTS ON NEWS 9 DAYBREAK ONE OF THE GRANITE STATE'S LARGEST SOLAR PROJECTS ...

Ezra Levin, co-executive director of Indivisible, talks with Rachel Maddow about the success of anti-Trump protests so far, and the remarkable participation in the massive day of protests planned for ...